Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
62.11
+6.24 (11.17%)
At close: Mar 9, 2026, 4:00 PM EDT
62.07
-0.04 (-0.06%)
After-hours: Mar 9, 2026, 7:02 PM EDT
Spruce Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 66 | 93 | 17 | 119 | 26 | 105 | |
| Market Cap Growth | 278.64% | 437.50% | -85.46% | 361.35% | -75.29% | -81.46% | |
| Enterprise Value | 11 | 84 | -39 | 16 | -58 | 19 | |
| Last Close Price | 55.87 | 87.11 | 31.50 | 219.75 | 82.31 | 334.50 | |
| PS Ratio | 46.53 | - | 3.53 | 11.82 | - | - | |
| PB Ratio | 5.85 | 2.19 | 0.60 | 1.56 | 0.38 | 0.94 | |
| P/TBV Ratio | 1.39 | 2.19 | 0.60 | 1.56 | 0.38 | 0.94 | |
| EV/Sales Ratio | - | - | - | 1.62 | - | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.10 | 0.06 | 0.09 | 0.06 | |
| Net Debt / Equity Ratio | -1.14 | -1.14 | -1.25 | -1.20 | -1.06 | -0.74 | |
| Net Debt / EBITDA Ratio | 1.33 | 1.33 | 0.64 | 1.77 | 1.54 | 1.96 | |
| Net Debt / FCF Ratio | 1.46 | 1.46 | 0.64 | 2.76 | 1.75 | 2.29 | |
| Asset Turnover | - | - | 0.07 | 0.11 | - | - | |
| Quick Ratio | 4.85 | 4.85 | 2.54 | 3.94 | 6.35 | 10.03 | |
| Current Ratio | 5.17 | 5.17 | 2.90 | 4.18 | 6.72 | 10.36 | |
| Return on Equity (ROE) | -109.24% | -109.24% | -100.70% | -66.10% | -51.35% | -32.43% | |
| Return on Assets (ROA) | -46.46% | -46.46% | -47.06% | -34.28% | -27.86% | -18.17% | |
| Return on Capital Employed (ROCE) | -85.00% | -85.00% | -187.40% | -65.40% | -64.60% | -35.80% | |
| Earnings Yield | -65.97% | -41.79% | -305.73% | -40.17% | -178.61% | -40.41% | |
| FCF Yield | -56.42% | -35.74% | -322.61% | -27.90% | -161.25% | -34.37% | |
| Buyback Yield / Dilution | -39.34% | -39.33% | -7.15% | -63.68% | -0.71% | -289.93% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.